About Us

At Batavia Biosciences, we work together to achieve our common goal, and we are constantly inspired by the dedication, teamwork, and expertise of our colleagues. We are proud to be a company where people come first, and we are committed to providing our employees with opportunities to reach their full potential.

The people making a difference

The company employs a highly educated staff with years of experience in DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization, and clinical manufacturing.

As such our facilities in USA and The Netherlands, are well-positioned to take on any challenge associated with the development of complex biological medicines be it proteins, antibodies, vaccines or viral vectors.

Our foundation.

Batavia Biosciences was founded in 2010 by Chris Yallop and Menzo Havenga. Chris build his career first on recombinant proteins and antibodies, while Menzo did the same on vaccines and viral vectors.

During their career, they experienced both the benefits and hurdles associated with outsourcing. Using that experience, they decided to build their own contract development and manufacturing organization, positioned to help clients from an early idea through process development into clinical GMP manufacturing.

 

Mission & Vision

As a recognized centre of excellence in biopharmaceutical R&D and clinical manufacturing, Batavia Biosciences is driven to reduce human suffering from infectious disease and cancer.

Our vision and mission are carried by our staff, who are driven by their core values; drive, flexibility, quality and scientific excellence.

01/01/2010
01/01/2010

Foundation

Menzo Havenga and Chris Yallop founded, what was then still called, Batavia Bioservices. With a staff of 7 dedicated people, vaccine and therapeutic protein projects for the first customers were…

25/08/2011
25/08/2011

Acquistion Xendo

The acquisition gave Batavia access to simulated moving bed purification technology as well as infrastructure, and microbial process and product development. With the acquisition the company had doubled its staff.

03/03/2012
03/03/2012

US Market

Batavia Bioservices Inc. launches laboratory infrastructure in the Greater Boston area. 10,000 ft2 of dedicated BSL-2 laboratories are fully equipped to accommodate the increasing market demand from the US.

24/10/2012
24/10/2012

Asian Market

In 2014 the company opened an office in Hong Kong to serve the growing order portfolio in Asia.

 Guides Towards Excellence.

The management team of our CDMO brings together decades of experience in the pharmaceutical and biotech industries, providing the expertise necessary to successfully navigate the complex drug development process.

Dr. Christopher Yallop

Dr. Christopher Yallop

Chief Operations Officer

Dr. Menzo Havenga

Dr. Menzo Havenga

President & CEO

Dr. Ron van Eijsden

Dr. Ron van Eijsden

Chief Business Officer

Claire Harrison

Claire Harrison

General Counsel

Pablo Mendes de León

Pablo Mendes de León

Chief Financial Officer

Low-cost viral vector manufacturing

High-throughput screening for viral vectors

Viral vector manufacturing

Maximizing protein expression